[1] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [J]. CA: a cancer journal for clinicians, 2009, 59(4)∶225-249 [2] Choi S, Myers J N. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy [J]. Journal of dental research, 2008, 87(1)∶14-32 [3] Shintani S, Nakahara Y, Mihara M, et al. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas [J]. Oral oncology, 2001, 37(6)∶498-504 [4] Nakahara Y, Shintani S, Mihara M, et al. Detection of p16 promoter methylation in the serum of oral cancer patients [J]. International journal of oral and maxillofacial surgery, 2006, 35(4)∶362-365 [5] Maquat LE. Nuclear mRNA export [J]. Current opinion in cell biology, 1991, 3(6)∶1004-1012 [6] Fujimoto A, O’Day SJ, Taback B, et al. Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome [J]. Cancer research, 2004, 64(12)∶4085-4088 [7] Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer [J]. Nature reviews genetics, 2002, 3(6)∶415-428 [8] Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA [J]. Nature, 1988, 334(6180)∶320-325 [9] Gallie DR. The cap and poly (A) tail function synergistically to regulate mRNA translational efficiency [J]. Genes & Development, 1991, 5(11)∶2108-2116 [10] Brawerman G. The Role of the Poly (A) Sequence in Mammalian Messenger RN [J]. Critical Reviews in Biochemistry and Molecular Biology, 1981, 10(1)∶1-38 [11] Peng J, Murray E L, Schoenberg D R. In vivo and in vitro analysis of poly (A) length effects on mRNA translation[M]//Post-Transcriptional Gene Regulation. Humana Press, 2008∶215-230 [12] Mockey M, Gonalves C, Dupuy FP, et al. mRNA transfection of dendritic cells: mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level, Biochem.Biophys [J]. Biochemical and biophysical research communications, 2006, 340(4)∶1062-1068 [13] Schwartz DC, Parker R. mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E [J]. Molecular and cellular biology, 2000, 20(21)∶7933-7942 [14] Seal R, Temperley R, Wilusz J, et al. Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability [J]. Nucleic acids research, 2005, 33(1)∶376-387 [15] Borman A M, Michel Y M, Malnou C E, et al. Free poly (A) stimulates capped mRNA translation in vitro through the eIF4G-poly (A)-binding protein interaction [J]. Journal of Biological Chemistry, 2002, 277(39)∶36818-36824 [16] Newbury S F. Control of mRNA stability in eukaryotes [J]. Biochemical Society Transactions, 2006, 34(1)∶30-34 [17] Lu Z X, Jiang P, Xing Y. Genetic variation of pre-mRNA alternative splicing in human populations [J]. Wiley Interdisciplinary Reviews: RNA, 2012, 3(4)∶581-592 [18] Wang E T, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes [J]. Nature, 2008, 456(7221)∶470-476 [19] Siddiqui N, Borden KLB. mRNA export and cancer [J]. Wiley Interdisciplinary Reviews: RNA, 2012, 3(1)∶13-25 [20] Strambio-De-Castillia C, Niepel M, Rout M P. The nuclear pore complex: bridging nuclear transport and gene regulation [J]. Nature Reviews Molecular Cell Biology, 2010, 11(7)∶490-501 [21] Culjkovic-Kraljacic B, Borden KLB. Aiding and abetting cancer: mRNA export and the nuclear pore [J]. Trends in cell biology, 2013, 23(7)∶328-335 [22] He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene [J]. nature, 2005, 435(7043)∶828-833 [23] O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression [J]. nature, 2005, 435(7043)∶839-843 [24] Carthew RW. Gene regulation by microRNAs [J]. Current opinion in genetics & development, 2006, 16(2)∶203-208 [25] 江方方,赵玮,胡逢春,等.反义miR-222靶向上调PUMA基因表达促进口腔鳞状细胞癌凋亡[J].中华口腔医学研究杂志(电子版),2013,03∶201-206 [26] Mishra R, Das B R. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression [J]. Archives of oral biology, 2009, 54(10)∶ 917-923 [27] Talwar S, Jin J, Carroll B, et al. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress [J]. Journal of Biological Chemistry, 2011, 286(37)∶32333-32343 [28] Katz J, Jakymiw A, Ducksworth M K, et al. CIP2A expression and localization in oral carcinoma and dysplasia [J]. Cancer biology & therapy, 2010, 10(7)∶694-699 [29] Li Q, Zhao J Z, Chen Y N, et al. Mutation and expression of tumor suppressor gene phosphatase and tensin homolog deleted in chromosome 10 in oral squamous cell carcinoma [J]. Zhonghua kou qiang yi xue za zhi= Zhonghua kouqiang yixue zazhi= Chinese journal of stomatology, 2009, 44(11)∶660-663 [30] 张同韩,刘海潮,梁玉洁,等.Notch 信号通路分子在舌鳞癌中的表达及意义[J].华西口腔医学杂志, 2013, 31(3)∶303-309 [31] 李田.Hedgehog信号通路分子在舌鳞状细胞癌中的表达及其临床意义[D].南京大学,2013 [32] Iamaroon A, Krisanaprakornkit S. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma [J]. Oral oncology, 2009, 45(10)∶e175-e179 [33] Wang K, Lin C, Wang C, et al. Silencing Kif2a induces apoptosis in squamous cell carcinoma of the oral tongue through inhibition of the PI3K/Akt signaling pathway [J]. Molecular medicine reports, 2014, 9(1)∶273-278 [34] Baba T, Sakamoto Y, Kasamatsu A, et al. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway [J]. Molecular carcinogenesis, 2013 [35] Katase N, Lefeuvre M, Tsujigiwa H, et al. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma derived cells [J]. Oncology reports, 2013, 29(4)∶1349-1355 [36] Shinozuka K, Uzawa K, Fushimi K, et al. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis [J]. Oncology, 2009, 76(6)∶387-397 [37] Yamano Y, Uzawa K, Shinozuka K, et al. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma [J]. International journal of oncology, 2008, 32(5)∶1001-1009 |